{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:06:06Z","timestamp":1781831166403,"version":"3.54.5"},"reference-count":30,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1999,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The effect of antibiotics on the acute lung injury induced by virulent\n            <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n            PA103 was quantitatively analyzed in a rat model. Lung injury was induced by the instillation of PA103 directly into the right lower lobes of the lungs of anesthetized rats. The alveolar epithelial injury, extravascular lung water, and total plasma equivalents were measured as separate, independent parameters of acute lung injury. Four hours after the instillation of PA103, all the parameters were increased linearly depending on the dose of\n            <jats:italic>P. aeruginosa<\/jats:italic>\n            . Next, we examined the effects of intravenously administered antibiotics on the parameters of acute lung injury in\n            <jats:sc>d<\/jats:sc>\n            -galactosamine-sensitized rats. One hour after the rats received 10\n            <jats:sup>7<\/jats:sup>\n            CFU of PA103, an intravenous bolus injection of aztreonam (60 mg\/kg) or imipenem-cilastatin (30 mg\/kg) was administered. Despite an MIC indicating resistance, imipenem-cilastatin improved all the measurements of lung injury; in contrast, aztreonam, which had an MIC indicating sensitivity, did not improve any of the lung injury parameters. The antibiotics did not generate different quantities of plasma endotoxin; therefore, endotoxin did not appear to explain the differences in lung injury. This in vivo model is useful to quantitatively compare the efficacies of parenteral antibiotic administration on\n            <jats:italic>Pseudomonas<\/jats:italic>\n            airspace infections.\n          <\/jats:p>","DOI":"10.1128\/aac.43.10.2389","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T20:33:30Z","timestamp":1539030810000},"page":"2389-2394","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":17,"title":["Effects of Antibiotic Therapy on\n            <i>Pseudomonas aeruginosa<\/i>\n            -Induced Lung Injury in a Rat Model"],"prefix":"10.1128","volume":"43","author":[{"given":"Erika J.","family":"Ernst","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->College of Pharmacy, University of Iowa, Iowa City, Iowa 522421;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Department of Anesthesiology and Intensive Care Unit, Kyoto Prefectural University of Medicine, Kyoto, Japan 6022;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Guglielmo","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Department of Clinical Pharmacy,3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiji","family":"Sawa","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Department of Anesthesia and Perioperative Care,4 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Pittet","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Department of Anesthesia and Perioperative Care,4 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Kropp","sequence":"additional","affiliation":[{"name":"<!--label omitted: 6-->Merck Research Laboratories, Rahway, New Jersey, 070656"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse J.","family":"Jackson","sequence":"additional","affiliation":[{"name":"<!--label omitted: 6-->Merck Research Laboratories, Rahway, New Jersey, 070656"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine P.","family":"Wiener-Kronish","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Department of Anesthesia and Perioperative Care,4 and"},{"name":"<!--label omitted: 7-->Department of Medicine and Cardiovascular Research Institute,7 University of California, San Francisco, California 94143; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/jac\/23.2.290","article-title":"Aztreonam in infections due to aerobic gram-negative bacteria.","volume":"23","author":"Allen K. D.","year":"1989","unstructured":"Allen K. D. Green H. T. Aztreonam in infections due to aerobic gram-negative bacteria. J. Antimicrob. Chemother. 23 1989 290 291","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1055\/s-0038-1646289","article-title":"Influence of the xanthine derivative HWA 138 on endotoxin-related coagulation disturbances: effects in non-sensitized vs. D-galactosamine sensitized rats.","volume":"68","author":"Bahrami S.","year":"1992","unstructured":"Bahrami S. Redl H. Buurman W. A. Schlag G. Influence of the xanthine derivative HWA 138 on endotoxin-related coagulation disturbances: effects in non-sensitized vs. D-galactosamine sensitized rats. Thromb. Haemost. 68 1992 418 423","journal-title":"Thromb. Haemost."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.7326\/0003-4819-103-4-552","article-title":"Imipenem: first of a new class of beta-lactam antibiotics.","volume":"103","author":"Barza M.","year":"1985","unstructured":"Barza M. Imipenem: first of a new class of beta-lactam antibiotics. Ann. Intern. Med. 103 1985 552 560","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(85)90097-X","article-title":"Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem\/cilastatin.","volume":"78","author":"Birnbaum J. F.","year":"1987","unstructured":"Birnbaum J. F. Kahan M. Kropp H. MacDonald J. S. Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem\/cilastatin. Am. J. Med. 78 1987 3 21","journal-title":"Am. J. Med."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jac\/23.3.401","article-title":"The pharmacokinetics of aztreonam and penetration into the bronchial secretions of critically ill patients.","volume":"23","author":"Boccazzi A.","year":"1989","unstructured":"Boccazzi A. Langer M. Mandeli M. Ranzi A. M. Urso R. The pharmacokinetics of aztreonam and penetration into the bronchial secretions of critically ill patients. J. Antimicrob. Chemother. 23 1989 401 407","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.109.4.1019"},{"key":"e_1_3_2_8_2","first-page":"96","article-title":"Aztreonam, a review of its antibacterial activity, pharmacokinetic properties and therapeutic use.","volume":"31","author":"Brogden R. N.","year":"1986","unstructured":"Brogden R. N. Heel R. C. Aztreonam, a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 31 1986 96 130","journal-title":"Drugs"},{"key":"e_1_3_2_9_2","first-page":"408","article-title":"Imipenem\/cilastatin, a reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.","volume":"44","author":"Buckley M. M.","year":"1992","unstructured":"Buckley M. M. Brogden R. N. Barradell L. B. Goa K. L. Imipenem\/cilastatin, a reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 44 1992 408 444","journal-title":"Drugs"},{"key":"e_1_3_2_10_2","first-page":"32","article-title":"Nosocomial pneumonia in mechanically ventilated adult patients: epidemiology and prevention in 1996.","volume":"11","author":"Craven D. E.","year":"1996","unstructured":"Craven D. E. Steger K. Nosocomial pneumonia in mechanically ventilated adult patients: epidemiology and prevention in 1996. Semin. Respir. Infect. 11 1996 32 53","journal-title":"Semin. Respir. Infect."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF02013112","article-title":"Selection and properties of Pseudomonas aeruginosa variants resistant to beta-lactam antibiotics.","volume":"6","author":"Cullmann W.","year":"1987","unstructured":"Cullmann W. Buscher K. H. Dick W. Selection and properties of Pseudomonas aeruginosa variants resistant to beta-lactam antibiotics. Eur. J. Clin. Microbiol. 6 1987 467 473","journal-title":"Eur. J. Clin. Microbiol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.8.1137"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549109024303"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199604000-00002"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90060-3"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0171-2985(11)80349-9","article-title":"Mechanisms of endotoxin shock and endotoxin hypersensitivity.","volume":"187","author":"Galanos C.","year":"1993","unstructured":"Galanos C. Freudenberg M. A. Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiology 187 1993 346 356","journal-title":"Immunobiology"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.11.5939"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/jac\/38.5.809","article-title":"Aerosolization of imipenem\/cilastatin prevents pseudomonas-induced acute lung injury.","volume":"38","author":"Hashimoto S.","year":"1996","unstructured":"Hashimoto S. Wolfe E. Guglielmo B. Shanks R. Sundelof J. Pittet J. F. Thomas E. Wiener-Kronish J. Aerosolization of imipenem\/cilastatin prevents pseudomonas-induced acute lung injury. J. Antimicrob. Chemother. 38 1996 809 818","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/infdis\/165.6.1033","article-title":"\u03b2-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP-3-specific ceftazidime.","volume":"165","author":"Jackson J. J.","year":"1992","unstructured":"Jackson J. J. Kropp H. \u03b2-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP-3-specific ceftazidime. J. Infect. Dis. 165 1992 1033 1041","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/AAC.26.2.119","article-title":"Disposition of [14C]aztreonam in rats, dogs, and monkeys.","volume":"26","author":"Kripilani K. J.","year":"1984","unstructured":"Kripilani K. J. Singhvi S. M. Weinstein S. H. Everett D. W. Bathala M. S. Dean A. V. Ita C. E. Lawrence L. Meeker F. S. Jr. Shaw J. M. Walker B. D. Migdalof B. H. Disposition of [14C]aztreonam in rats, dogs, and monkeys. Antimicrob. Agents Chemother. 26 1984 119 126","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_21_2","first-page":"L511","article-title":"Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar injury.","volume":"267","author":"Kudoh I.","year":"1994","unstructured":"Kudoh I. Wiener-Kronish J. P. Hashimoto S. Pittet J.-F. Frank D. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar injury. Am. J. Physiol. 267 1994 L511 L516","journal-title":"Am. J. Physiol."},{"key":"e_1_3_2_22_2","unstructured":"National Committee for Clinical Laboratory Standards\n          Methods for determining dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A4.\n          1997\n          National Committee for Clinical Laboratory Standards\n          Wayne Pa"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-3-227"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199604000-00001"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.12.3269"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/151.6.1012"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/jac\/21.4.471","article-title":"Imipenem\/cilastatin, an alternative treatment of Pseudomonas infection in cystic fibrosis.","volume":"21","author":"Stradvik G.","year":"1988","unstructured":"Stradvik G. Malmborg A. S. Bergan T. Michalsen H. Storrosten O. T. Wretlind B. Imipenem\/cilastatin, an alternative treatment of Pseudomonas infection in cystic fibrosis. J. Antimicrob. Chemother. 21 1988 471 480","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1378\/chest.108.3.786","article-title":"Bacteremic nosocomial pneumonia. A 7-year experience in one institution.","volume":"108","author":"Taylor G. D.","year":"1994","unstructured":"Taylor G. D. Buchanan-Chell M. Kirkland T. McKenzie M. Wiens R. Bacteremic nosocomial pneumonia. A 7-year experience in one institution. Chest 108 1994 786 788","journal-title":"Chest"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/142.3.523"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1172\/JCI115388","article-title":"Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin.","volume":"88","author":"Wiener-Kronish J. P.","year":"1991","unstructured":"Wiener-Kronish J. P. Albertine K. H. Matthay M. A. Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J. Clin. Investig. 88 1991 864 875","journal-title":"J. Clin. Investig."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1993.75.4.1661"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.43.10.2389","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.43.10.2389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T10:51:44Z","timestamp":1645440704000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.43.10.2389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1999,10]]}},"alternative-id":["10.1128\/AAC.43.10.2389"],"URL":"https:\/\/doi.org\/10.1128\/aac.43.10.2389","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,10]]},"assertion":[{"value":"1999-04-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-07-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-10-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}